Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement.

Ting Wang,Neil McAuslane,Wim G Goettsch,Hubert G M Leufkens,Marie L De Bruin

International journal of technology assessment in health care（2023）

引用 0|浏览12

暂无评分

摘要

This research brought together regulators, HTA agencies, companies to examine how they interact with one another. We propose measures of value and make recommendations on future evolution to enable better evidence generation and improve regulatory and HTA decision-making.

查看译文

关键词

Collaboration,Early scientific advice,Evidentiary requirement,Health technology assessment,Stakeholder interactions

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要